$12.30
-0.16-1.28%
Last update: Nov 5, 4:00 PM
Pharming Group (PHAR) Stock Price, Quote, News & History
PHARNASDAQ
FDA issued a CRL to Pharming's Joenja child use filing, citing dosing concerns in lower-weight kids and testing issues.
You can purchase shares of Pharming (NASDAQ:PHAR) through any online brokerage.
Other companies in Pharming’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Pharming has a consensus price target of $34.40.
The stock price for Pharming (NASDAQ: PHAR) is $12.73 last updated November 4, 2026 at 9:27 AM EST.
There are no upcoming dividends for Pharming.
Pharming does not have any upcoming earnings scheduled.
There is no upcoming split for Pharming.
Pharming is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with...
